FundingWatcher
Home / Investors / Post IPO investors / Post IPO investors in DACH

Post IPO investors in DACH

Updated 16 Nov 2026

Reset

Venture funds

2 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Nextech Invest
Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio.
Zürich, Switzerland
Health care, Biotech Early stage venture, Late stage venture 31% 2
2 Novartis Venture Fund
Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics.
Basel, Switzerland
Health care, Biotech Seed, Early stage venture, Late stage venture 27% 2

Table 1. Post IPO investors in DACH: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Post IPO investors in DACH
One-time CSV
  • 55 firms, 52 with a website
  • 35 firm email addresses
  • 27 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-post-ipo-investors-dach.csv55 rows × 15 columns
InvestorTypeLocationEmailPhone
Deutsche BankInvestment bankFrankfurt, Germany•••@db.com+49 69•••
Novartis Venture FundCorporate venture armBasel, Switzerland•••@sosei.com877 28•••
HBM Healthcare InvestmentsVenture capital firmZug, Switzerland•••@hbmhealthcare.com+41 41•••
Wellington PartnersVenture capital firmMunich, Germany•••@wellington-partners.com+44 20•••
UBSCorporate venture armZürich, Switzerland•••@ubs.com41 44 •••
Rocket InternetStartup incubatorBerlin, Germany•••@rocket-internet.com
VI PartnersVenture capital firmAltendorf, Switzerland•••@vipartners.ch+41 41•••
Nextech InvestVenture capital firmZürich, Switzerland•••@nextechinvest.com41 (0)•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

55
Investors
35
With email
27
With phone
12
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Post IPO investors in DACH

30 of 55, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Deutsche Bank Investment bank Frankfurt, Germany Fintech, Artificial intelligence Synthesized, Partior, Blueground 304 102 132 •••@db.com +49 69••• In the CSV
2 Novartis Venture Fund Corporate venture arm, Venture capital firm Basel, Switzerland Health care, Biotech Hepalink, FoRx Therapeutics 2 279 75 77 •••@sosei.com 877 28•••
3 HBM Healthcare Investments Venture capital firm Zug, Switzerland Biotech, Health care 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics 260 47 90 •••@hbmhealthcare.com +41 41•••
4 Wellington Partners Venture capital firm Munich, Germany Health care, Biotech nyra health 1 252 80 65 •••@wellington-partners.com +44 20••• In the CSV
5 UBS Corporate venture arm, Fund of funds Zürich, Switzerland Fintech, Hardware SWISSto12, MerQube, Nasdaq Private Market 3 157 53 53 •••@ubs.com 41 44 ••• In the CSV
6 Rocket Internet Startup incubator, Private equity firm Berlin, Germany Fintech, Commerce enshift 1 155 43 52 •••@rocket-internet.com In the CSV
7 VI Partners Venture capital firm Altendorf, Switzerland Health care, Biotech L.E.S.S. 1 111 26 22 •••@vipartners.ch +41 41••• In the CSV
8 Nextech Invest Venture capital firm Zürich, Switzerland Health care, Biotech Circle Pharma, Atavistik Bio 2 100 31 43 •••@nextechinvest.com 41 (0)••• In the CSV
9 BASF Venture Capital Corporate venture arm Ludwigshafen, Germany Biotech, Artificial intelligence Computomics 1 88 35 18 973 24••• In the CSV
10 responsAbility Investments AG Fund of funds, Private equity firm Zürich, Switzerland Fintech, Commerce Koa Switzerland, Investree, ePaylater 74 42 11 •••@responsability.com +41 44••• In the CSV
11 Partners Group Private equity firm Baar, Switzerland Hardware, Artificial intelligence Neara, Akur8, Sirion 74 39 34 •••@partnersgroup.com 212 90••• In the CSV
12 Monkfish Equity Venture capital firm Leipzig, Germany Hardware, Artificial intelligence Tractive, TopCheck, Pixsy 53 6 18 •••@monkfish-equity.com +49 32••• In the CSV
13 Heliad AG Private equity firm, Venture capital firm Frankfurt, Germany Fintech, Commerce FINN 1 46 25 9 •••@heliad.com +49 69••• In the CSV
14 3B Future Health Fund Venture capital firm Monaco, Germany Biotech, Health care Navion Neurosciences 1 36 11 5 •••@helsinn.com +377 9••• In the CSV
15 Barclays Bank Investment bank Hamburg, Germany 35 14 22 •••@barclays.de 0800 1••• In the CSV
16 dRx Capital Corporate venture arm, Venture capital firm Basel, Switzerland Biotech, Health care Dopavision 31 4 8 In the CSV
17 Pictet Private Equity Investors S.A. Investment bank Geneva, Switzerland Artificial intelligence, Biotech Unique AI, Harbinger Health, Red Date Technology 30 4 6 •••@pictet.com In the CSV
18 Nice & Green SA Investment bank, Private equity firm Nyon, Switzerland 29 26 20 •••@nicengreen.ch In the CSV
19 ABACON Fund of funds, Hedge fund Hamburg, Germany Artificial intelligence, Energy Entrix 1 28 4 7 •••@abacon.capital In the CSV
20 TVM Capital Life Science Venture capital firm Munich, Germany Health care, Biotech leon nanodrugs, Smart Reporting, Myo 25 17 4 •••@tvm-capital.com +49899••• In the CSV
21 Armada Investment AG Family office, Private equity firm Kusnacht, Switzerland Energy, Fintech Last Energy 1 19 5 5 •••@armada.com +41 44••• In the CSV
22 Allianz Global Investors Private equity firm Munich, Germany 17 6 6 •••@allianzgi.de +49 92••• In the CSV
23 kineo finance Venture debt fund Basel, Switzerland 15 7 0 In the CSV
24 Egora Holding Venture capital firm Martinsried, Germany 13 5 3 •••@egoraholding.com +49 (0••• In the CSV
25 Oesterreichische Entwicklungsbank AG Investment bank Vienna, Austria 12 6 5 +43 1 ••• In the CSV
26 Kliwla Family Office Family office, Hedge fund Vaduz, Liechtenstein 9 0 3 •••@kliwla.com
27 New Energy Capital Private equity firm Hanover, Germany 8 5 2 •••@newenergycapital.com 603.64••• In the CSV
28 Obotritia Capital Private equity firm, Venture capital firm Potsdam, Germany Fintech Arrago 1 7 3 1 •••@obocap.com +49 (0••• In the CSV
29 BayernLB Capital Partner Venture capital firm Munich, Germany 6 2 3 •••@bayernlb-cp.de
30 DDM Group Private equity firm Baar, Switzerland ClimateCamp 5 3 2 +41417••• In the CSV

Table 2. Post IPO investors in DACH: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 55.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 UBS Zürich, Switzerland 3 26 SWISSto12, MerQube, Nasdaq Private Market
2 Nextech Invest Zürich, Switzerland 2 5 Circle Pharma, Atavistik Bio
3 Novartis Venture Fund Basel, Switzerland 2 20 Hepalink, FoRx Therapeutics
4 3B Future Health Fund Monaco, Germany 1 2 Navion Neurosciences
5 BASF Venture Capital Ludwigshafen, Germany 1 8 Computomics
6 Heliad AG Frankfurt, Germany 1 4 FINN
7 ABACON Hamburg, Germany 1 5 Entrix
8 VI Partners Altendorf, Switzerland 1 19 L.E.S.S.
9 Wellington Partners Munich, Germany 1 36 nyra health
10 Armada Investment AG Kusnacht, Switzerland 1 2 Last Energy
11 Obotritia Capital Potsdam, Germany 1 2 Arrago
12 Rocket Internet Berlin, Germany 1 21 enshift

Table 3. Post IPO investors in DACH: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco, United States Series E $92.5M 2026-09-16 $300.0M Nextech Invest 11 to 50 2012
Navion Neurosciences Navion Neurosciences develops sodium channel therapeutics for neurological diseases at a pre-clinical stage. Artificial intelligence Charlottesville, United States Seed $10.8M 2026-09-09 $21.2M 3B Future Health Fund 1 to 10 2021
Computomics Computomics applies artificial intelligence to genomics data to advance agricultural solutions. Artificial intelligence Tübingen, Germany Series B $7.3M 2026-08-18 $10.0M BASF Venture Capital 11 to 50 2012
SWISSto12 SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. Hardware Renens, Switzerland Series C $70.0M 2026-07-16 $202.3M UBS 251 to 500 2011
FINN FINN offers car subscriptions that let you drive vehicles without long-term purchase or lease commitments. Commerce Munich, Germany Series D $113.4M 2026-06-24 $2.2B Heliad AG 251 to 500 2019
MerQube MerQube provides technology for rules-based investment strategies and passive index design. Fintech San Francisco, United States Series C $30.0M 2026-04-13 $67.0M UBS 51 to 100 2019
Entrix Entrix provides software and services for operating energy storage and renewable energy assets. Artificial intelligence Munich, Germany Series B $49.9M 2026-03-25 $74.8M ABACON 101 to 250 2021
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Cambridge, United States Series B $40.0M 2026-03-05 $260.0M Nextech Invest 11 to 50 2021
nyra health Nyra Health offers an AI and evidence-based neurological research tablet app for therapy. Artificial intelligence Vienna, Austria Series A $23.6M 2026-02-24 $28.5M Wellington Partners 11 to 50 2020
Nasdaq Private Market Nasdaq Private Market provides a marketplace where private companies, banks, brokers, and investors transact. Fintech San Francisco, United States Series C $37.6M 2026-01-16 $143.9M UBS 51 to 100 2013

Table 4. Post IPO investors in DACH: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 126 62%
Health care 53 26%
Fintech 52 26%
Biotech 43 21%
Artificial intelligence 36 18%
Hardware 31 15%
Commerce 16 8%
Cybersecurity 8 4%
Energy 5 2%
Education 4 2%

Table 5. Post IPO investors in DACH: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Post IPO investors in DACH by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesInvestorsShare
Switzerland 26 47%
Germany 25 45%
Austria 2 4%
Liechtenstein 2 4%

Table 7. Post IPO investors in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Munich 6 11%
Berlin 6 11%
Frankfurt 5 9%
Zürich 5 9%
Basel 4 7%
Geneva 4 7%
Baar 2 4%
Hamburg 2 4%
Vienna 2 4%
Vaduz 2 4%
Zug 1 2%
Altendorf 1 2%

Table 8. Post IPO investors in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 3 7%
2010s 9 20%
2000s 19 42%
1990s 6 13%
1980s 1 2%
1960s 2 4%

Table 9. Post IPO investors in DACH by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many post ipo investors in DACH are on the list?
55, in the file dated 16 November 2026. 12 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
35 of the 55 carry an email address in the download and 27 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 55 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 55 rows, 35 firm email addresses and 27 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 22 of the 35 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Post IPO investors in DACH: 55 rows, CSV, $29 one-time.

At once: the CSV with 55 rows, 35 firm email addresses and 27 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 22 of the 35 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Investor types in DACH

Other stages in DACH

Post IPO investors elsewhere

Cite: FundingWatcher, 55 post ipo investors in DACH, 16 November 2026. https://fundingwatcher.com/investors/stage/post-ipo-investors/dach/